Literature DB >> 20419776

Urologic management of spina bifida.

Douglass B Clayton1, John W Brock, David B Joseph.   

Abstract

The urologist plays an important role in the multidisciplinary team of physicians who provide care for patients with spina bifida. We review common strategies for managing the urinary tract in these patients. The primary objective in all phases of life is protecting kidney function by minimizing bladder hostility and establishing a good capacity, low-pressure urinary reservoir. Ensuring adequate bladder and bowel continence is also paramount for enhancing self-esteem and independence. Medical therapy incorporating clean intermittent catheterization and antimuscarinic medication is the cornerstone of neurogenic bladder management and often the only intervention required to achieve the above goals. Others may require formal lower urinary tract reconstruction to prevent urinary tract deterioration. As will be shown, current management, while effective, is not supported by strong evidence-based protocols; and the impact of any intervention upon quality of life, while subjectively seen as positive, does not have objective validation. These limitations are recognized and currently the subject of urologic investigation.

Entities:  

Mesh:

Year:  2010        PMID: 20419776     DOI: 10.1002/ddrr.92

Source DB:  PubMed          Journal:  Dev Disabil Res Rev        ISSN: 1940-5529


  14 in total

Review 1.  Who needs surgery for pediatric myelomeningocele? A retrospective study and literature review.

Authors:  Humberto Marreiros; Clara Loff; Eulália Calado
Journal:  J Spinal Cord Med       Date:  2014-07-16       Impact factor: 1.985

2.  Cotransplantation with specific populations of spina bifida bone marrow stem/progenitor cells enhances urinary bladder regeneration.

Authors:  Arun K Sharma; Matthew I Bury; Natalie J Fuller; Andrew J Marks; David M Kollhoff; Manoj V Rao; Partha V Hota; Derek J Matoka; Seby L Edassery; Hatim Thaker; John F Sarwark; Joseph A Janicki; Guillermo A Ameer; Earl Y Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

3.  Quality of life of very young spina bifida patients after initial surgical treatment.

Authors:  Kirtikumar Jagdish Rathod; J K Mahajan; Rizwan Ahmad Khan; K L N Rao
Journal:  Childs Nerv Syst       Date:  2012-01-17       Impact factor: 1.475

4.  Introduction: Spina bifida--a multidisciplinary perspective.

Authors:  Jack M Fletcher; Timothy J Brei
Journal:  Dev Disabil Res Rev       Date:  2010

5.  Percutaneous nephrolithotomy in adult patients with spina bifida, severe spinal deformity and large renal stones.

Authors:  M Alsinnawi; W C Torreggiani; R Flynn; T E D McDermott; R Grainger; J A Thornhill
Journal:  Ir J Med Sci       Date:  2012-12-10       Impact factor: 1.568

6.  The association between urinary continence and quality of life in paediatric patients with spina bifida and tethered cord.

Authors:  Jamie D Olesen; Darcie A Kiddoo; Peter D Metcalfe
Journal:  Paediatr Child Health       Date:  2013-08       Impact factor: 2.253

7.  Implementing motivational interviewing in a pediatric hospital.

Authors:  Timothy R Apodaca; Sarah L Tsai; Melissa K Miller; Michele H Maddux; Diane Kennedy; Kelly Trowbridge
Journal:  Mo Med       Date:  2014 May-Jun

8.  Different clinical electrodes achieve similar electrical nerve conduction block.

Authors:  Adam Boger; Narendra Bhadra; Kenneth J Gustafson
Journal:  J Neural Eng       Date:  2013-08-28       Impact factor: 5.379

9.  Characteristics and survival of patients with end stage renal disease and spina bifida in the United States renal data system.

Authors:  Lijing Ouyang; Julie Bolen; Rodolfo Valdez; David Joseph; Michelle A Baum; Judy Thibadeau
Journal:  J Urol       Date:  2014-08-25       Impact factor: 7.450

10.  Design and Methodological Considerations of the Centers for Disease Control and Prevention Urologic and Renal Protocol for the Newborn and Young Child with Spina Bifida.

Authors:  Jonathan C Routh; Earl Y Cheng; J Christopher Austin; Michelle A Baum; Patricio C Gargollo; Richard W Grady; Adrienne R Herron; Steven S Kim; Shelly J King; Chester J Koh; Pangaja Paramsothy; Lisa Raman; Michael S Schechter; Kathryn A Smith; Stacy T Tanaka; Judy K Thibadeau; William O Walker; M Chad Wallis; John S Wiener; David B Joseph
Journal:  J Urol       Date:  2016-07-27       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.